Selecta Biosciences
Clinical-stage biopharmaceutical company developing targeted immunotherapies using its ImmTOR platform to induce immune tolerance. Publicly traded on NASDAQ (SELB). Technology enables patients to receive gene therapies and other biologics without immune rejection.
Website
https://www.selectabio.comLocation
Watertown, Massachusetts, USA
Founded
2007
Investors
1
Categories
biotech, immunotherapy, drug-delivery, gene-therapy, public-company
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Polaris Partners | US | biotech-focused | - | 33 |